title: The use of lepirudin in haemodialysis complicated with heparin-induced thrombocytopenia type II (HIT II)--dosage monitoring.
authors.forename: Theodoros Ioannis
authors.initials: TI
authors.lastname: Kassimatis
authors.forename: Theofanis
authors.initials: T
authors.lastname: Apostolou
authors.forename: Theodoros
authors.initials: T
authors.lastname: Theodoridis
authors.forename: Mahmut
authors.initials: M
authors.lastname: El Ali
authors.forename: Valsamakis
authors.initials: V
authors.lastname: Hadjiconstantinou
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D011994:Recombinant Proteins; D006493:Heparin; C083544:lepirudin